| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.091 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |